Postdoctoral Researcher Fellow

Rafal Gulej was born in Poland, where he completed his pharmaceutical education. In 2018, he came to Oklahoma as a Fulbright Scholar, where he conducted research on novel therapeutics with potential applications in glioblastoma, neurodegeneration, and aging. Following this fellowship, Rafal pursued his PhD studies investigating how age-related changes in plasma bioactive factors contribute to cerebrovascular decline and dementia. He has recently joined Dr. Yabluchanskiy’s laboratory, where he applies his molecular biology expertise to study changes in plasma factors during aging, disease, and in response to therapeutic interventions, extending this work to patient samples alongside preclinical models.

Education:
2020 PharmD, Bio-Organic Chemistry, Medical University of Lodz, Lodz, Poland
2024 PhD in Neuroscience, University of Oklahoma Health Science Center, Oklahoma City, USA
2025 Postdoctoral Training, Vascular Cognitive Impairment and Neurodegeneration Program, University of Oklahoma Health Science Center, Oklahoma City, USA